StockData
IN8bio, Inc. logo

IN8bio, Inc. (INAB) stock

INABNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.77−0.01 (-0.97%)

Close on Nov 19, 2026Market cap $7.61MP/E –Yield –

IN8bio shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

IN8bio's shares outstanding was 19M at Jun 30, 2026. For fiscal 2025 it was 4M, up 145.1% from the year before. The highest annual figure on record is 4M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20254M+145.1%
FY2024Dec 31, 20242M+79.3%
FY2023Dec 31, 20231M+42.4%
FY2022Dec 31, 20221M+110.3%
FY2021Dec 31, 20210M+191.6%
FY2020Dec 31, 20200M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202619M+372.6%
Q1 FY2026Mar 31, 202619M+655.9%
Q4 FY2025Dec 31, 20257M+173.7%
Q3 FY2025Sep 30, 20255M+187.7%
Q2 FY2025Jun 30, 20254M+162.9%
Q1 FY2025Mar 31, 20253M+78.5%
Q4 FY2024Dec 31, 20243M+124.8%
Q3 FY2024Sep 30, 20242M+50.0%
Q2 FY2024Jun 30, 20242M+65.1%
Q1 FY2024Mar 31, 20241M+75.0%
Q4 FY2023Dec 31, 20231M+41.1%
Q3 FY2023Sep 30, 20231M+45.6%
Q2 FY2023Jun 30, 20231M+51.2%
Q1 FY2023Mar 31, 20231M+31.6%
Q4 FY2022Dec 31, 20221M+30.1%
Q3 FY2022Sep 30, 20221M+61.9%
Q2 FY2022Jun 30, 20221M+400.2%
Q1 FY2022Mar 31, 20221M+399.4%
Q4 FY2021Dec 31, 20211M+447.5%
Q3 FY2021Sep 30, 20210M+270.1%
Q2 FY2021Jun 30, 20210M+8.7%
Q1 FY2021Mar 31, 20210M–
Q4 FY2020Dec 31, 20200M–
Q3 FY2020Sep 30, 20200M–
Q2 FY2020Jun 30, 20200M–

More IN8bio figures

See a number that looks wrong?